216 related articles for article (PubMed ID: 16923959)
1. Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145.
Terada Y; Yasuda Y
Mol Cell Biol; 2006 Nov; 26(21):8149-58. PubMed ID: 16923959
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 Vpr interacts with spliceosomal protein SAP145 to mediate cellular pre-mRNA splicing inhibition.
Hashizume C; Kuramitsu M; Zhang X; Kurosawa T; Kamata M; Aida Y
Microbes Infect; 2007 Apr; 9(4):490-7. PubMed ID: 17347016
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation.
Zimmerman ES; Chen J; Andersen JL; Ardon O; Dehart JL; Blackett J; Choudhary SK; Camerini D; Nghiem P; Planelles V
Mol Cell Biol; 2004 Nov; 24(21):9286-94. PubMed ID: 15485898
[TBL] [Abstract][Full Text] [Related]
4. ATR and GADD45alpha mediate HIV-1 Vpr-induced apoptosis.
Andersen JL; Zimmerman ES; DeHart JL; Murala S; Ardon O; Blackett J; Chen J; Planelles V
Cell Death Differ; 2005 Apr; 12(4):326-34. PubMed ID: 15650754
[TBL] [Abstract][Full Text] [Related]
5. Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest.
Belzile JP; Abrahamyan LG; Gérard FC; Rougeau N; Cohen EA
PLoS Pathog; 2010 Sep; 6(9):e1001080. PubMed ID: 20824083
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.
Belzile JP; Duisit G; Rougeau N; Mercier J; Finzi A; Cohen EA
PLoS Pathog; 2007 Jul; 3(7):e85. PubMed ID: 17630831
[TBL] [Abstract][Full Text] [Related]
7. Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo.
Lai M; Zimmerman ES; Planelles V; Chen J
J Virol; 2005 Dec; 79(24):15443-51. PubMed ID: 16306615
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.
Andersen JL; DeHart JL; Zimmerman ES; Ardon O; Kim B; Jacquot G; Benichou S; Planelles V
PLoS Pathog; 2006 Dec; 2(12):e127. PubMed ID: 17140287
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest.
Zhou Y; Ratner L
J Virol; 2000 Jul; 74(14):6520-7. PubMed ID: 10864665
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes.
Zhu Y; Gelbard HA; Roshal M; Pursell S; Jamieson BD; Planelles V
J Virol; 2001 Apr; 75(8):3791-801. PubMed ID: 11264368
[TBL] [Abstract][Full Text] [Related]
11. The role of Vpr in HIV-1 disease progression is independent of its G2 arrest induction function.
Lai M; Chen J
Cell Cycle; 2006 Oct; 5(19):2275-80. PubMed ID: 16969134
[TBL] [Abstract][Full Text] [Related]
12. A carboxy-terminally truncated form of the Vpr protein of human immunodeficiency virus type 1 retards cell proliferation independently of G(2) arrest of the cell cycle.
Nishizawa M; Myojin T; Nishino Y; Nakai Y; Kamata M; Aida Y
Virology; 1999 Oct; 263(2):313-22. PubMed ID: 10544105
[TBL] [Abstract][Full Text] [Related]
13. DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest.
Tan L; Ehrlich E; Yu XF
J Virol; 2007 Oct; 81(19):10822-30. PubMed ID: 17626091
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved.
Forget J; Yao XJ; Mercier J; Cohen EA
J Mol Biol; 1998 Dec; 284(4):915-23. PubMed ID: 9837715
[TBL] [Abstract][Full Text] [Related]
15. Yeast perspectives on HIV-1 VPR.
Zhao Y; Elder RT
Front Biosci; 2000 Dec; 5():D905-16. PubMed ID: 11102318
[TBL] [Abstract][Full Text] [Related]
16. Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest.
Henklein P; Bruns K; Sherman MP; Tessmer U; Licha K; Kopp J; de Noronha CM; Greene WC; Wray V; Schubert U
J Biol Chem; 2000 Oct; 275(41):32016-26. PubMed ID: 10903315
[TBL] [Abstract][Full Text] [Related]
17. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.
Mahalingam S; Ayyavoo V; Patel M; Kieber-Emmons T; Weiner DB
J Virol; 1997 Sep; 71(9):6339-47. PubMed ID: 9261351
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.
DeHart JL; Zimmerman ES; Ardon O; Monteiro-Filho CM; Argañaraz ER; Planelles V
Virol J; 2007 Jun; 4():57. PubMed ID: 17559673
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection.
Hrimech M; Yao XJ; Bachand F; Rougeau N; Cohen EA
J Virol; 1999 May; 73(5):4101-9. PubMed ID: 10196306
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.
Zimmerman ES; Sherman MP; Blackett JL; Neidleman JA; Kreis C; Mundt P; Williams SA; Warmerdam M; Kahn J; Hecht FM; Grant RM; de Noronha CM; Weyrich AS; Greene WC; Planelles V
J Virol; 2006 Nov; 80(21):10407-18. PubMed ID: 16956949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
